Global Atherectomy Devices Market

Atherectomy Devices Market Size, Share, Growth Analysis, By Product (Directional Atherectomy Devices, Orbital Atherectomy Devices), By Application (Peripheral Vascular, Cardiovascular,), By End User, By Region - Industry Forecast 2025-2032

Report ID: SQMIG35A2953 | Region: Global | Published Date: November, 2024
Pages: 186 | Tables: 64 | Figures: 64

Atherectomy Devices Market Insights

Atherectomy Devices Market size was valued at USD 962.41 Million in 2023 and is poised to grow from USD 1040.37 Million in 2024 to USD 1939.96 Million by 2032, growing at a CAGR of 8.1% during the forecast period (2025-2032).

Surging prevalence of cardiovascular disorders around the world is projected to primarily augment the sales of atherectomy devices going forward. Rapidly increasing geriatric population, poor lifestyle choices, and unhealthy eating habits are contributing to the high incidence of cardiovascular disorders thereby favoring the demand for atherectomy devices as well. Rising popularity of minimally invasive devices and procedures around the world is also expected to create new opportunities for atherectomy devices providers in the future. Moreover, high investments in medical R&D are also predicted to result in advancements in atherectomy device technologies, which in turn offers new opportunities for atherectomy devices providers. On the contrary, high costs of atherectomy procedures and devices, risk of complications, and availability of alternatives are estimated to impede atherectomy devices market growth potential in the long run.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Atherectomy Devices Market size was valued at around USD 890.30 million in 2022 and is expected to rise from USD 962.41 million in 2023 to reach a value of USD 1794.60 million by 2031, at a CAGR of 8.1% over the forecast period (2024–2031).

Developing affordable and advanced atherectomy devices will be the prime focus of new as well as established companies in the future. Atherectomy devices providers can also maximize their business scope by riding the wave of minimally invasive surgery popularity going forward. Investing in research and development will be an unmissable strategy for all atherectomy devices companies working in this market. Emerging countries will provide attractive growth opportunities for atherectomy devices suppliers in the long run. 'Medtronic Plc (Ireland) ', 'Boston Scientific Corporation (USA) ', 'Cardiovascular Systems, Inc. (USA) ', 'Royal Philips (Netherlands) ', 'Avinger, Inc. (USA) ', 'Terumo Corporation (Japan) ', 'AngioDynamics, Inc. (USA) ', 'Braun Group (Germany) ', 'Abbott Laboratories (USA) ', 'B. Braun Melsungen AG (Germany) ', 'Biotronik SE & Co. KG (Germany) ', 'Biomerics (USA) ', 'Philips (Netherlands) ', 'Cook Medical, Inc. (USA) ', 'Cardinal Health, Inc. (USA) ', 'Rex Medical, L.P. (USA) ', 'W. L. Gore & Associates, Inc. (USA) ', 'Minnetronix, Inc. (USA) ', 'Merit Medical Systems, Inc. (USA) ', 'NexStep Medical (USA)'

An aging population is more at risk of suffering from cardiovascular complications such as arterial blockages. Atherectomy devices are crucial in helping treat these disorders and growing preference for minimally invasive atherectomy procedures among geriatric people will also bolster atherectomy devices market growth in the future.

Integration of Advanced Technologies: Atherectomy device manufacturers should focus on integrating advanced technologies such as artificial intelligence and machine learning to improve the capabilities of their offerings. Companies can deploy these advanced technologies in their development as well as deployment to maximize business scope in the future.

North America is projected to account for a dominant share of the global atherectomy devices market. High incidence of multiple cardiovascular disorders and growing number of atherectomy procedures in this region allow it to hold a dominant stance. Rapidly increasing geriatric population, rising popularity of minimally invasive surgeries, and approvals of novel atherectomy devices are also expected to contribute to this region's dominance. The United States is projected to spearhead sales of atherectomy devices in the North American region followed by Canada. High healthcare expenditure in this region will also favor atherectomy device sales.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Surgical Stapling Devices Market
Buy Now GET FREE SAMPLE
Transradial Access Devices Market
Buy Now GET FREE SAMPLE
Dermatology Devices Market
Buy Now GET FREE SAMPLE
Ophthalmology Devices Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Atherectomy Devices Market

Report ID: SQMIG35A2953

$5,300
BUY NOW GET FREE SAMPLE